Patients Whole Genome Reveals Disease Risks, Drug Responses
Scientists at Stanford and Harvard Universities collaborated to assess the clinical usefulness of analyzing a patients full genome for disease risks and unusual drug responses. The work brings closer to reality the concept that whole-genome sequencing might one day play a clinical role.
Read More